Atavistik | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

7 results for “Atavistik”

Trials

Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

250 participants · First posted Feb 19, 2015

Drugs

ATV-1601

Manufacturer: Atavistik Bio

Conditions: Hereditary Hemorrhagic Telangiectasia

News

Roche signs backloaded $2B allosteric small-molecule deal with Atavistik Bio for CVRM diseases

Atavistik Bio Unveils Novel JAK2 V617F Mutant-Selective Inhibitors for Myeloproliferative Neoplasms at ASH 2025

Atavistik Bio Secures FDA IND Clearance and Fast Track Designation for ATV-1601 in Hereditary Hemorrhagic Telangiectasia